Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?

Drug induced liver injury (DILI) is a potentially serious adverse reaction in a few susceptible individuals under therapy by various drugs. Health care professionals facing DILI are confronted with a wealth of drug-unrelated liver diseases with high incidence and prevalence rates, which can confound...

Descripción completa

Detalles Bibliográficos
Autores principales: Teschke, Rolf, Schulze, Johannes, Eickhoff, Axel, Danan, Gaby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412387/
https://www.ncbi.nlm.nih.gov/pubmed/28398242
http://dx.doi.org/10.3390/ijms18040803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412387/
https://www.ncbi.nlm.nih.gov/pubmed/28398242
http://dx.doi.org/10.3390/ijms18040803

Ejemplares similares